Mini Review
Absolute Dpcr Quantification of Micrornas by Absolute Dpcr for the Diagnostic Screening of Colon Cancer
Received Date: February 18, 2019; Published Date: February 27, 2019
Abstract
Colorectal cancer (CRC) is the third most common malignancy worldwide, with an estimated one million new cases and half million deaths yearly. Screening for CRC allows early stage diagnosis of malignancy and potentially reduces disease mortality. The convenient and inexpensive fecal occult blood test (FOBT) screening test has low sensitivity and requires dietary restriction, which impedes compliance. Although colonoscopy. Is the golden screening standard for the for this cancer, the invasive nature, abdominal pain and high cost have hampered worldwide application of this procedure. A noninvasive sensitive screen for colon cancer (CC) requiring no dietary restriction is a more convenient test. CC is more abundant in the USA than rectal cancer (RC).
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
